Primary Care Community Partnerships to Prevent Diabetes (RAPID)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
RAckermann, Northwestern University
ClinicalTrials.gov Identifier:
NCT00656682
First received: April 10, 2008
Last updated: June 5, 2013
Last verified: June 2013

April 10, 2008
June 5, 2013
April 2008
August 2013   (final data collection date for primary outcome measure)
% Change in Body Weight [ Time Frame: 12 months ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00656682 on ClinicalTrials.gov Archive Site
  • % Change in Blood Total Cholesterol [ Time Frame: 12 months ] [ Designated as safety issue: No ]
  • % Change in glycosylated hemoglobin [ Time Frame: 12 months ] [ Designated as safety issue: No ]
  • % Change in Blood Pressures [ Time Frame: 12 months ] [ Designated as safety issue: No ]
  • Changes in Dietary Composition [ Time Frame: 12 months ] [ Designated as safety issue: No ]
  • Changes in Physical Activity [ Time Frame: 12 months ] [ Designated as safety issue: No ]
  • Incremental Costs [ Time Frame: 12 months ] [ Designated as safety issue: No ]
  • Incremental Health State Utility [ Time Frame: 12 months ] [ Designated as safety issue: No ]
  • % Change in Body Weight [ Time Frame: 6 months ] [ Designated as safety issue: No ]
  • % Change in Body Weight [ Time Frame: 24 months ] [ Designated as safety issue: No ]
  • % Change in Blood Total Cholesterol [ Time Frame: 12 months ] [ Designated as safety issue: No ]
  • % Change in A1C [ Time Frame: 12 months ] [ Designated as safety issue: No ]
  • % Change in Blood Pressures [ Time Frame: 12 months ] [ Designated as safety issue: No ]
  • Changes in Dietary Composition [ Time Frame: 12 months ] [ Designated as safety issue: No ]
  • Changes in Physical Activity [ Time Frame: 12 months ] [ Designated as safety issue: No ]
  • Incremental Costs [ Time Frame: 12 months ] [ Designated as safety issue: No ]
  • Incremental Health State Utility [ Time Frame: 12 months ] [ Designated as safety issue: No ]
  • % Change in Body Weight [ Time Frame: 6 months ] [ Designated as safety issue: No ]
  • % Change in Body Weight [ Time Frame: 24 months ] [ Designated as safety issue: No ]
Not Provided
Not Provided
 
Primary Care Community Partnerships to Prevent Diabetes
Primary Care Community Partnerships to Prevent Diabetes

The purpose of this study is to determine if providing free-of-charge access to a group-based lifestyle intervention delivered in partnership with the community is cost-effective for the prevention of type 2 diabetes.

Randomized controlled trials have shown that modest lifestyle changes can prevent or delay the onset of diabetes in adults with pre-diabetes. Unfortunately, despite the increasing prevalence of pre-diabetes and diabetes in all facets of the population, intervention programs needed to achieve these goals are costly and remain unavailable in most clinical settings. Over the past 3 years, we have demonstrated the feasibility of training community instructors to deliver a group-based adaptation of the Diabetes Prevention Program (DPP) lifestyle intervention. In this pilot research, this new delivery model achieves a level of weight reduction that was associated with diabetes prevention and improved cardiometabolic risk factor control in the DPP. This new, large-scale randomized effectiveness trial is designed to evaluate the costs and effectiveness of a partnered approach to identify adults with pre-diabetes in primary care settings, deliver brief advice for diabetes prevention, and provide access to a group-based adaptation of the DPP lifestyle intervention offered by the community. This study will compare costs and outcomes to a standard care, brief clinical counseling approach delivered by Registered Dietitians.

Interventional
Phase 2
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Prevention
  • Hyperglycemia
  • Obesity
  • Diabetes Mellitus
  • Behavioral: Dietitian Counseling Alone
    Primary care-based identification of pre-diabetes with brief counseling by a dedicated registered dietitian
  • Behavioral: Dietitian Plus Community Group Lifestyle
    Primary care-based identification of pre-diabetes with brief counseling by a dedicated registered dietitian, PLUS free-of-charge access to a group-based lifestyle intervention offered by the Community to prevent diabetes
  • Active Comparator: Dietitian Counseling Alone
    Primary care-based identification of pre-diabetes with brief counseling by a dedicated registered dietitian. Registered Dietitian Counseling Alone
    Intervention: Behavioral: Dietitian Counseling Alone
  • Experimental: Dietitian Plus Community Group Lifestyle
    Primary care-based identification of pre-diabetes with brief counseling by a dedicated registered dietitian, PLUS free-of-charge access to a group-based diabetes prevention lifestyle intervention offered by the community. Dietitian Counseling Plus Community Group Lifestyle Intervention.
    Intervention: Behavioral: Dietitian Plus Community Group Lifestyle
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
510
Not Provided
August 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • 18 years of age or older
  • Body-mass index of 24 kg/m2 or greater
  • Fasting Blood Glucose 100 - 125 mg/dl, OR 2-hour Post-challenge Capillary Glucose 140 - 199 mg/dl

Exclusion Criteria:

  • Cancer requiring treatment in the past 5 years
  • Uncontrolled hypertension: systolic blood pressure >180 mmHg or diastolic blood pressure >105 mmHg
  • Heart attack, stroke, or transient ischemic attack in the past 6 months,
  • Chronic obstructive airways disease or asthma requiring home oxygen
  • Other chronic disease or condition, such as advanced arthritis, that could limit ability to become physically active or limit life span to <5 years
  • Pregnancy
  • Existing diagnosis of diabetes mellitus
  • Fasting capillary blood glucose > 125 mg/dl
  • 2-hour post-challenge capillary blood glucose > 199 mg/dl
  • History of anti-diabetic medication use (oral agents or insulin) except during gestational diabetes
  • Self-report of a medication known to lead to hyperglycemia (oral steroids, antipsychotics, anti-epileptics)
  • Self-report of disease associated with disordered glucose metabolism: Cushing's syndrome; acromegaly; pheochromocytoma; chronic pancreatitis
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00656682
R18 DK79855, R18DK079855
Yes
RAckermann, Northwestern University
Northwestern University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Principal Investigator: Ronald T Ackermann, MD, MPH Northwestern University School of Medicine
Northwestern University
June 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP